aluates Reports

$ 0.0

Automative

Global Solid Organ Transplantation Rejection (SOT) Market Research Report 2026

Published Date: 2026-03-27

Report Code: QYRE-Auto-11P17520

Global Solid Organ Transplantation Rejection SOT Market Research Report 2024

BUY CHAPTERS

Global Solid Organ Transplantation Rejection (SOT) Market Research Report 2026

Code: QYRE-Auto-11P17520

Report

2026-03-27

Pages:101

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis

Terumo

Roche

Astellas Pharma

Preservation Solutions

Transmedic

Pfizer Inc

Sanofi

Veloxis Pharmaceuticals

Solid Organ Transplantation Rejection (SOT) Market

The global Solid Organ Transplantation Rejection (SOT) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The North American market for Solid Organ Transplantation Rejection (SOT) is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Solid Organ Transplantation Rejection (SOT) is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Solid Organ Transplantation Rejection (SOT) in Hospital is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Solid Organ Transplantation Rejection (SOT) include Novartis, Terumo, Roche, Astellas Pharma, Preservation Solutions, Transmedic, Pfizer, Sanofi, Veloxis Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Solid Organ Transplantation Rejection (SOT) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Solid Organ Transplantation Rejection (SOT). The Solid Organ Transplantation Rejection (SOT) market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Solid Organ Transplantation Rejection (SOT) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Solid Organ Transplantation Rejection (SOT) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Solid Organ Transplantation Rejection (SOT) Market Report

Report Metric	Details
Report Name	Solid Organ Transplantation Rejection (SOT) Market
Segment by Type	Kidney Heart Liver
Segment by Application	Hospital Transplant Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis, Terumo, Roche, Astellas Pharma, Preservation Solutions, Transmedic, Pfizer, Sanofi, Veloxis Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Solid Organ Transplantation Rejection (SOT) companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Solid Organ Transplantation Rejection (SOT) Market report?

Ans: The main players in the Solid Organ Transplantation Rejection (SOT) Market are Novartis, Terumo, Roche, Astellas Pharma, Preservation Solutions, Transmedic, Pfizer, Sanofi, Veloxis Pharmaceuticals

What are the Application segmentation covered in the Solid Organ Transplantation Rejection (SOT) Market report?

Ans: The Applications covered in the Solid Organ Transplantation Rejection (SOT) Market report are Hospital, Transplant Centers, Others

What are the Type segmentation covered in the Solid Organ Transplantation Rejection (SOT) Market report?

Ans: The Types covered in the Solid Organ Transplantation Rejection (SOT) Market report are Kidney, Heart, Liver

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Kidney

1.2.3 Heart

1.2.4 Liver

1.3 Market by Application

1.3.1 Global Solid Organ Transplantation Rejection (SOT) Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospital

1.3.3 Transplant Centers

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Solid Organ Transplantation Rejection (SOT) Market Perspective (2021–2032)

2.2 Global Solid Organ Transplantation Rejection (SOT) Growth Trends by Region

2.2.1 Global Solid Organ Transplantation Rejection (SOT) Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Solid Organ Transplantation Rejection (SOT) Historic Market Size by Region (2021–2026)

2.2.3 Solid Organ Transplantation Rejection (SOT) Forecasted Market Size by Region (2027–2032)

2.3 Solid Organ Transplantation Rejection (SOT) Market Dynamics

2.3.1 Solid Organ Transplantation Rejection (SOT) Industry Trends

2.3.2 Solid Organ Transplantation Rejection (SOT) Market Drivers

2.3.3 Solid Organ Transplantation Rejection (SOT) Market Challenges

2.3.4 Solid Organ Transplantation Rejection (SOT) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Solid Organ Transplantation Rejection (SOT) Players by Revenue

3.1.1 Global Top Solid Organ Transplantation Rejection (SOT) Players by Revenue (2021–2026)

3.1.2 Global Solid Organ Transplantation Rejection (SOT) Revenue Market Share by Players (2021–2026)

3.2 Global Top Solid Organ Transplantation Rejection (SOT) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Solid Organ Transplantation Rejection (SOT) Revenue

3.4 Global Solid Organ Transplantation Rejection (SOT) Market Concentration Ratio

3.4.1 Global Solid Organ Transplantation Rejection (SOT) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Solid Organ Transplantation Rejection (SOT) Revenue in 2025

3.5 Global Key Players of Solid Organ Transplantation Rejection (SOT) Head Offices and Areas Served

3.6 Global Key Players of Solid Organ Transplantation Rejection (SOT), Products and Applications

3.7 Global Key Players of Solid Organ Transplantation Rejection (SOT), Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Solid Organ Transplantation Rejection (SOT) Breakdown Data by Type

4.1 Global Solid Organ Transplantation Rejection (SOT) Historic Market Size by Type (2021–2026)

4.2 Global Solid Organ Transplantation Rejection (SOT) Forecasted Market Size by Type (2027–2032)

5 Solid Organ Transplantation Rejection (SOT) Breakdown Data by Application

5.1 Global Solid Organ Transplantation Rejection (SOT) Historic Market Size by Application (2021–2026)

5.2 Global Solid Organ Transplantation Rejection (SOT) Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Solid Organ Transplantation Rejection (SOT) Market Size (2021–2032)

6.2 North America Solid Organ Transplantation Rejection (SOT) Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Solid Organ Transplantation Rejection (SOT) Market Size by Country (2021–2026)

6.4 North America Solid Organ Transplantation Rejection (SOT) Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Solid Organ Transplantation Rejection (SOT) Market Size (2021–2032)

7.2 Europe Solid Organ Transplantation Rejection (SOT) Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Solid Organ Transplantation Rejection (SOT) Market Size by Country (2021–2026)

7.4 Europe Solid Organ Transplantation Rejection (SOT) Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size (2021–2032)

8.2 Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size by Region (2021–2026)

8.4 Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Solid Organ Transplantation Rejection (SOT) Market Size (2021–2032)

9.2 Latin America Solid Organ Transplantation Rejection (SOT) Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Solid Organ Transplantation Rejection (SOT) Market Size by Country (2021–2026)

9.4 Latin America Solid Organ Transplantation Rejection (SOT) Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size (2021–2032)

10.2 Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size by Country (2021–2026)

10.4 Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis

11.1.1 Novartis Company Details

11.1.2 Novartis Business Overview

11.1.3 Novartis Solid Organ Transplantation Rejection (SOT) Introduction

11.1.4 Novartis Revenue in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)

11.1.5 Novartis Recent Development

11.2 Terumo

11.2.1 Terumo Company Details

11.2.2 Terumo Business Overview

11.2.3 Terumo Solid Organ Transplantation Rejection (SOT) Introduction

11.2.4 Terumo Revenue in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)

11.2.5 Terumo Recent Development

11.3 Roche

11.3.1 Roche Company Details

11.3.2 Roche Business Overview

11.3.3 Roche Solid Organ Transplantation Rejection (SOT) Introduction

11.3.4 Roche Revenue in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)

11.3.5 Roche Recent Development

11.4 Astellas Pharma

11.4.1 Astellas Pharma Company Details

11.4.2 Astellas Pharma Business Overview

11.4.3 Astellas Pharma Solid Organ Transplantation Rejection (SOT) Introduction

11.4.4 Astellas Pharma Revenue in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)

11.4.5 Astellas Pharma Recent Development

11.5 Preservation Solutions

11.5.1 Preservation Solutions Company Details

11.5.2 Preservation Solutions Business Overview

11.5.3 Preservation Solutions Solid Organ Transplantation Rejection (SOT) Introduction

11.5.4 Preservation Solutions Revenue in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)

11.5.5 Preservation Solutions Recent Development

11.6 Transmedic

11.6.1 Transmedic Company Details

11.6.2 Transmedic Business Overview

11.6.3 Transmedic Solid Organ Transplantation Rejection (SOT) Introduction

11.6.4 Transmedic Revenue in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)

11.6.5 Transmedic Recent Development

11.7 Pfizer

11.7.1 Pfizer Company Details

11.7.2 Pfizer Business Overview

11.7.3 Pfizer Solid Organ Transplantation Rejection (SOT) Introduction

11.7.4 Pfizer Revenue in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)

11.7.5 Pfizer Recent Development

11.8 Sanofi

11.8.1 Sanofi Company Details

11.8.2 Sanofi Business Overview

11.8.3 Sanofi Solid Organ Transplantation Rejection (SOT) Introduction

11.8.4 Sanofi Revenue in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)

11.8.5 Sanofi Recent Development

11.9 Veloxis Pharmaceuticals

11.9.1 Veloxis Pharmaceuticals Company Details

11.9.2 Veloxis Pharmaceuticals Business Overview

11.9.3 Veloxis Pharmaceuticals Solid Organ Transplantation Rejection (SOT) Introduction

11.9.4 Veloxis Pharmaceuticals Revenue in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)

11.9.5 Veloxis Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Novartis

Terumo

Roche

Astellas Pharma

Preservation Solutions

Transmedic

Pfizer Inc

Sanofi

Veloxis Pharmaceuticals

List of Tables

Table 1. Global Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Kidney

Table 3. Key Players of Heart

Table 4. Key Players of Liver

Table 5. Global Solid Organ Transplantation Rejection (SOT) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Solid Organ Transplantation Rejection (SOT) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Solid Organ Transplantation Rejection (SOT) Market Size by Region (US$ Million), 2021–2026

Table 8. Global Solid Organ Transplantation Rejection (SOT) Market Share by Region (2021–2026)

Table 9. Global Solid Organ Transplantation Rejection (SOT) Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Solid Organ Transplantation Rejection (SOT) Market Share by Region (2027–2032)

Table 11. Solid Organ Transplantation Rejection (SOT) Market Trends

Table 12. Solid Organ Transplantation Rejection (SOT) Market Drivers

Table 13. Solid Organ Transplantation Rejection (SOT) Market Challenges

Table 14. Solid Organ Transplantation Rejection (SOT) Market Restraints

Table 15. Global Solid Organ Transplantation Rejection (SOT) Revenue by Players (US$ Million), 2021–2026

Table 16. Global Solid Organ Transplantation Rejection (SOT) Market Share by Players (2021–2026)

Table 17. Global Top Solid Organ Transplantation Rejection (SOT) Players by Tier (Tier 1, Tier 2, and Tier 3), based on Solid Organ Transplantation Rejection (SOT) Revenue, 2025

Table 18. Ranking of Global Top Solid Organ Transplantation Rejection (SOT) Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Solid Organ Transplantation Rejection (SOT) Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Solid Organ Transplantation Rejection (SOT), Headquarters and Area Served

Table 21. Global Key Players of Solid Organ Transplantation Rejection (SOT), Products and Applications

Table 22. Global Key Players of Solid Organ Transplantation Rejection (SOT), Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Solid Organ Transplantation Rejection (SOT) Market Size by Type (US$ Million), 2021–2026

Table 25. Global Solid Organ Transplantation Rejection (SOT) Revenue Market Share by Type (2021–2026)

Table 26. Global Solid Organ Transplantation Rejection (SOT) Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Solid Organ Transplantation Rejection (SOT) Revenue Market Share by Type (2027–2032)

Table 28. Global Solid Organ Transplantation Rejection (SOT) Market Size by Application (US$ Million), 2021–2026

Table 29. Global Solid Organ Transplantation Rejection (SOT) Revenue Market Share by Application (2021–2026)

Table 30. Global Solid Organ Transplantation Rejection (SOT) Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Solid Organ Transplantation Rejection (SOT) Revenue Market Share by Application (2027–2032)

Table 32. North America Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Solid Organ Transplantation Rejection (SOT) Market Size by Country (US$ Million), 2021–2026

Table 34. North America Solid Organ Transplantation Rejection (SOT) Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Solid Organ Transplantation Rejection (SOT) Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Solid Organ Transplantation Rejection (SOT) Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Solid Organ Transplantation Rejection (SOT) Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Solid Organ Transplantation Rejection (SOT) Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size by Country (US$ Million), 2027–2032

Table 47. Novartis Company Details

Table 48. Novartis Business Overview

Table 49. Novartis Solid Organ Transplantation Rejection (SOT) Product

Table 50. Novartis Revenue in Solid Organ Transplantation Rejection (SOT) Business (US$ Million), 2021–2026

Table 51. Novartis Recent Development

Table 52. Terumo Company Details

Table 53. Terumo Business Overview

Table 54. Terumo Solid Organ Transplantation Rejection (SOT) Product

Table 55. Terumo Revenue in Solid Organ Transplantation Rejection (SOT) Business (US$ Million), 2021–2026

Table 56. Terumo Recent Development

Table 57. Roche Company Details

Table 58. Roche Business Overview

Table 59. Roche Solid Organ Transplantation Rejection (SOT) Product

Table 60. Roche Revenue in Solid Organ Transplantation Rejection (SOT) Business (US$ Million), 2021–2026

Table 61. Roche Recent Development

Table 62. Astellas Pharma Company Details

Table 63. Astellas Pharma Business Overview

Table 64. Astellas Pharma Solid Organ Transplantation Rejection (SOT) Product

Table 65. Astellas Pharma Revenue in Solid Organ Transplantation Rejection (SOT) Business (US$ Million), 2021–2026

Table 66. Astellas Pharma Recent Development

Table 67. Preservation Solutions Company Details

Table 68. Preservation Solutions Business Overview

Table 69. Preservation Solutions Solid Organ Transplantation Rejection (SOT) Product

Table 70. Preservation Solutions Revenue in Solid Organ Transplantation Rejection (SOT) Business (US$ Million), 2021–2026

Table 71. Preservation Solutions Recent Development

Table 72. Transmedic Company Details

Table 73. Transmedic Business Overview

Table 74. Transmedic Solid Organ Transplantation Rejection (SOT) Product

Table 75. Transmedic Revenue in Solid Organ Transplantation Rejection (SOT) Business (US$ Million), 2021–2026

Table 76. Transmedic Recent Development

Table 77. Pfizer Company Details

Table 78. Pfizer Business Overview

Table 79. Pfizer Solid Organ Transplantation Rejection (SOT) Product

Table 80. Pfizer Revenue in Solid Organ Transplantation Rejection (SOT) Business (US$ Million), 2021–2026

Table 81. Pfizer Recent Development

Table 82. Sanofi Company Details

Table 83. Sanofi Business Overview

Table 84. Sanofi Solid Organ Transplantation Rejection (SOT) Product

Table 85. Sanofi Revenue in Solid Organ Transplantation Rejection (SOT) Business (US$ Million), 2021–2026

Table 86. Sanofi Recent Development

Table 87. Veloxis Pharmaceuticals Company Details

Table 88. Veloxis Pharmaceuticals Business Overview

Table 89. Veloxis Pharmaceuticals Solid Organ Transplantation Rejection (SOT) Product

Table 90. Veloxis Pharmaceuticals Revenue in Solid Organ Transplantation Rejection (SOT) Business (US$ Million), 2021–2026

Table 91. Veloxis Pharmaceuticals Recent Development

Table 92. Research Programs/Design for This Report

Table 93. Key Data Information from Secondary Sources

Table 94. Key Data Information from Primary Sources

Table 95. Authors List of This Report

List of Figures

Figure 1. Solid Organ Transplantation Rejection (SOT) Picture

Figure 2. Global Solid Organ Transplantation Rejection (SOT) Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Solid Organ Transplantation Rejection (SOT) Market Share by Type: 2025 vs 2032

Figure 4. Kidney Features

Figure 5. Heart Features

Figure 6. Liver Features

Figure 7. Global Solid Organ Transplantation Rejection (SOT) Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Solid Organ Transplantation Rejection (SOT) Market Share by Application: 2025 vs 2032

Figure 9. Hospital Case Studies

Figure 10. Transplant Centers Case Studies

Figure 11. Others Case Studies

Figure 12. Solid Organ Transplantation Rejection (SOT) Report Years Considered

Figure 13. Global Solid Organ Transplantation Rejection (SOT) Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Solid Organ Transplantation Rejection (SOT) Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Solid Organ Transplantation Rejection (SOT) Market Share by Region: 2025 vs 2032

Figure 16. Global Solid Organ Transplantation Rejection (SOT) Market Share by Players in 2025

Figure 17. Global Solid Organ Transplantation Rejection (SOT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Solid Organ Transplantation Rejection (SOT) Revenue in 2025

Figure 19. North America Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Solid Organ Transplantation Rejection (SOT) Market Share by Country (2021–2032)

Figure 21. United States Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Solid Organ Transplantation Rejection (SOT) Market Share by Country (2021–2032)

Figure 25. Germany Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Share by Region (2021–2032)

Figure 33. China Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Solid Organ Transplantation Rejection (SOT) Market Share by Country (2021–2032)

Figure 41. Mexico Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Share by Country (2021–2032)

Figure 45. Israel Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Novartis Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)

Figure 49. Terumo Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)

Figure 50. Roche Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)

Figure 51. Astellas Pharma Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)

Figure 52. Preservation Solutions Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)

Figure 53. Transmedic Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)

Figure 54. Pfizer Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)

Figure 55. Sanofi Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)

Figure 56. Veloxis Pharmaceuticals Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Heart Transplant Rejection Treatment Market Research Report 2025

Global Kidney Transplant Rejection Therapeutics Market Research Report 2024

Global Solid Organ Transplant Immunosuppressant Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Kidney Transplant Anti Rejection Drugs Market Research Report 2024

Organ Transplant Rejection Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Organ Transplant Anti rejection Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Organ Preservation Technology Market Research Report 2025

Global Organ Transplant Immunosuppressant Drugs Market Insights Forecast to 2030

Global Organ Transport Device Market Research Report 2024

Global Transplantation Therapeutics Drugs Market Research Report 2024

Global 3D Bioprinted Organ Transplant Market Research Report 2024

Global Organ Preservation Device Market Research Report 2024

Global Gamete Transplantation Market Research Report 2024

Global Organ Transportation Service Market Research Report 2025

Organ Rejection Prophylaxis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Transplant Drug Concentration Monitoring Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Solid Aseptic Transfer System Market Research Report 2024

Global Organ Transport Service Market Research Report 2025

Global Fecal Microbiota Transplantation FMT Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions